Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong · Delayed Price · Currency is HKD 54.65
+9.47 (20.96%)
At close: Mar 6, 2026
HKG:2315 Market Cap
HKG:2315 has a market cap or net worth of 35.6 billion as of March 6, 2026. Its market cap has increased by 1,066.58% in one year.
Market Cap
35.60B
Enterprise Value
35.74B
Revenue
1.53B
Ranking
n/a
PE Ratio
114.21
Stock Price
54.65
Market Cap Chart
Since September 1, 2022, HKG:2315's market cap has increased from 10.31B to 35.60B, an increase of 245.14%. That is a compound annual growth rate of 42.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 32.10B | 36.11% |
| Dec 31, 2025 | 23.58B | 594.71% |
| Dec 31, 2024 | 3.39B | -29.05% |
| Dec 29, 2023 | 4.78B | -53.29% |
| Dec 30, 2022 | 10.24B | -0.67% |
| Sep 1, 2022 | 10.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RemeGen | 51.52B |
| 3SBio | 49.10B |
| Shanghai Henlius Biotech | 34.84B |
| Shanghai Junshi Biosciences | 30.65B |
| Duality Biotherapeutics | 26.64B |
| TransThera Sciences (Nanjing) | 24.22B |
| Genscript Biotech | 23.70B |
| PegBio | 23.43B |